Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jun 10, 2004

Mylan Receives FDA Approval for Ciprofloxacin Tablets

May 11, 2004

Mylan Reports Record EPS, Revenues and Net Earnings for Fiscal 2004

May 06, 2004

Mylan Receives Tentative Approval for Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release Tablets

May 05, 2004

Mylan Submits New Drug Application for Nebivolol

Apr 29, 2004

Mylan Announces Earnings Release Date and Conference Call Information for Fourth Quarter and Fiscal 2004

Apr 22, 2004

Mylan Announces FDA Approval Of APOKYN NDA; A Novel Treatment in Parkinson's Disease

Apr 19, 2004

Mylan Confirms Mirtazapine Settlement

Apr 12, 2004

Mylan Dismissed From Massachusetts Multi-District AWP Litigation

Apr 05, 2004

Mylan Announces Tentative Approval for Risperidone Tablets; Potential First-to-File Opportunity

Apr 02, 2004

Mylan Responds to Alza's Letter to the FDA on Fentanyl

Pagination

First page
Previous page
…
Page 116
Page 117
Page 118
Page 119
Current page 120
Page 121
Page 122
Page 123
Page 124
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.